학술논문
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease
Document Type
Article
Author
Source
In: Cell Metabolism . (Cell Metabolism, 1 March 2022, 34(3):396-407.e6)
Subject
Language
English
ISSN
19327420
15504131
15504131